title: Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients.
authors.forename: Lisa G
authors.initials: LG
authors.lastname: van den Hengel
authors.forename: A Q M Jeanne
authors.initials: AQ
authors.lastname: van Steijn-van Tol
authors.forename: Rogier M
authors.initials: RM
authors.lastname: Bertina
authors.forename: Henri H
authors.initials: HH
authors.lastname: Versteeg
authors.forename: Susanne
authors.initials: S
authors.lastname: Osanto
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D055252:Cell-Derived Microparticles / Q000378:metabolism*; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D013736:Testicular Neoplasms / Q000097:blood* / Q000188:drug therapy* / Q000473:pathology; D013925:Thromboplastin / Q000378:metabolism*
chemical_list: D001761:Bleomycin; D005047:Etoposide; D013925:Thromboplastin; D002945:Cisplatin